Modell für Stroke Units und die Lysetherapie – Neue Studien und wichtige Erkenntnisse für die akute Schlaganfallbehandlung

In den letzten Jahren hat eine ganze Reihe neuer Studien wichtige Erkenntnisse für die akute Schlaganfallbehandlung erbracht. Die Lysetherapie hat sich bei einem breiten Patientenkollektiv – unabhängig vom Alter und Schweregrad – als wirksam erwiesen und der enge Zusammenhang zwischen Zeit bis zu Behandlungsbeginn und Wirksamkeit zwingt zu einer Optimierung der Versorgungstrukturen. Mit den neuen Studien zur endovaskulären Thrombektomie liegen erstmals auch überzeugende Daten zur Effektivität der intraarteriellen mechanischen Thrombusentfernung vor, die eine Anpassung der prähospitalen und klinischen Abläufe erfordern. Zentrales Element für eine funktionierende Akut-Schlaganfallversorgung ist und bleibt die Stroke Unit, die durch neue Netzwerkstrukturen erweitert und ergänzt wird.

In the past few years numerous new trials have revealed important information concerning acute stroke treatment. Lysis therapy has proved to be effective for a broad patient collective – irrespective of age and severity – and the close relationship between the time to treatment start and efficacy demands an optimization of health-care structures. With the MR CLEAN study convincing data have become available for the first time concerning the efficacy of intra-arterial mechanical clot removal that implicate an adaptation of the prehospital and clinical procedures. The central element for the functioning care of acute stroke patients is and will continue to be the stroke unit that will be expanded and supplemented by new network structures.

Key words

Acute stroke - stroke unit - recanalization therapies - lysis therapy - MR CLEAN study - intra-arterial mechanical clot removal - health-care network

• Literatur

• 1 Indredavik B. Stroke unit care is beneficial both for the patient and for the health service and should be widely implemented. Stroke 2009; 40: 1-2
• 2 Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. CD 000197 2013; 9
• 3 Seenan P, Long M, Langhorne P. Stroke units in their natural habitat: systematic review of observational studies. Stroke 2007; 38: 1886-1892
• 4 Audebert HJ, Schultes K, Tietz V et al. Long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical Project for Integrative Stroke Care (TEMPiS). Stroke 2009; 40: 902-908
• 5 Audebert HJ, Schenkel J, Heuschmann PU et al. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol 2006; 5: 742-748
• 6 Middleton S, McElduff P, Ward J et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet 2011; 378: 1699-1706
• 7 Indredavik B, Bakke F, Slordahl SA et al. Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important?. Stroke 1999; 30: 917-923
• 8 Bundes Gd. Sterbefälle, Sterbeziffern (je 100.000 Einwohner, altersstandardisiert) (ab 1998). [cited 2015 23.01.2015] Available from: https://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/WS0100/_XWD_PROC?_XWD_112/7/XWD_CUBE.DRILL/_XWD_140/D.946/14497 2015
• 9 Feigin VL, Forouzanfar MH, Krishnamurthi R et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383: 245-254
• 10 Sandercock P, Wardlaw JM, Lindley RI et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-2363
• 11 Emberson J, Lees KR, Lyden P et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929-1935
• 12 Schlaganfall-Hilfe SD. 250. Stroke Unit zertifiziert 2013 [cited 2015 23.01.2015]. Available from: http://www.presseportal.de/pm/23980/2623720/ 250-stroke-unit-zertifiziert-akutversorgung-von-schlaganfall-patienten-geschieht-auf-hohem-niveau
• 13 Schlaganfall-Gesellschaft D. Zertifizierte Stroke Units. 2015 [cited 2015 23.01.2015] Available from: http://www.dsg-info.de/stroke-units/stroke-units-uebersicht.html
• 14 Muller-Barna P, Hubert GJ, Boy S et al. TeleStroke Units Serving as a Model of Care in Rural Areas: 10-Year Experience of the TeleMedical Project for Integrative Stroke Care. Stroke 2014; 45: 2739-2744
• 15 From Clinical Trials to Bedside: Evaluating the Transfer of Scientific Insights to the Real-World Stroke Care in Germany by Comparison of Nation-Wide Administative Data. International Journal of Stroke. Abstract from the European Stroke Organisation Conference 2015;
• 16 Saver JL, Fonarow GC, Smith EE et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013; 309: 2480-2488
• 17 Wiedmann S, Hillmann S, Abilleira S et al. Variations in Acute Hospital Stroke Care and Factors Influencing Adherence to Quality Indicators in 6 European Audits. Stroke 2015; 46: 579-581
• 18 Sivenius J, Pyorala K, Heinonen OP et al. The significance of intensity of rehabilitation of stroke – a controlled trial. Stroke 1985; 16: 928-931
• 19 Stevens RS, Ambler NR, Warren MD. A randomized controlled trial of a stroke rehabilitation ward. Age and ageing 1984; 13: 65-75
• 20 Feldman DJ, Lee PR, Unterecker J et al. A comparison of functionally orientated medical care and formal rehabilitation in the management of patients with hemiplegia due to cerebrovascular disease. J chronic dis 1962; 15: 297-310
• 21 Indredavik B, Bakke F, Solberg R et al. Benefit of a stroke unit: a randomized controlled trial. Stroke 1991; 22: 1026-1031
• 22 Ronning OM, Guldvog B. Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trial. Stroke 1998; 29: 586-590
• 23 Ronning OM, Guldvog B. Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial. Stroke 1998; 29: 58-62
• 24 Sulter G, Elting JW, Langedijk M et al. Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study. Stroke 2003; 34: 101-104
• 25 Cavallini A, Micieli G, Marcheselli S, Quaglini S. Role of monitoring in management of acute ischemic stroke patients. Stroke 2003; 34: 2599-2603
• 26 Kalra L, Evans A, Perez I et al. Alternative strategies for stroke care: a prospective randomised controlled trial. Lancet 2000; 356: 894-899
• 27 Audebert HJ, Wimmer ML, Hahn R et al. Can telemedicine contribute to fulfill WHO Helsingborg Declaration of specialized stroke care?. Cerebrovasc Dis 2005; 20: 362-369
• 28 Morris S, Hunter RM, Ramsay AI et al. Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis. BMJ 2014; 349
• 29 Bray BD, Ayis S, Campbell J et al. Associations between the organisation of stroke services, process of care, and mortality in England: prospective cohort study. BMJ 2013; 346
• 30 Audebert HJ, Kukla C, Clarmann von Claranau S et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005; 36: 287-291
• 31 Wendt M, Ebinger M, Kunz A et al. Improved pre-hospital triage of stroke patients in a specialized stroke ambulance – Results of the PHANTOM-S study. Stroke 2015; 46: 740-745
• 32 Lees KR, Bluhmki E, von Kummer R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703
• 33 Kitzrow M, Bartig D, Krogias C et al. Quality parameters in the treatment of acute stroke: comparison of various regional treatment concepts. Der Nervenarzt 2013; 84: 1486-1496
• 34 Schwab S, Vatankhah B, Kukla C et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 2007; 69: 898-903
• 35 Bray BD, Campbell J, Cloud GC et al. Bigger, faster? Associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke. Stroke 2013; 44: 3129-3135
• 36 Heuschmann PU, Kolominsky-Rabas PL, Roether J et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA 2004; 292: 1831-1838
• 37 Meretoja A, Strbian D, Mustanoja S et al. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 2012; 79: 306-313
• 38 Hubert GJ, Meretoja A, Audebert H et al. Comparison of stroke thrombolysis rates and delays in a centralized (Helsinki, Finland) and decentralized (Tempis Telestroke Unit Network, Germany) setting. Int J Stroke 2014; 9: 41-331
• 39 Ebinger M, Rozanski M, Waldschmidt C et al. PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients – study. Int J Stroke 2012; 7: 348-353
• 40 Schwamm LH, Starkman S. Have CT will travel: To boldly go where no scan has gone before. Neurology 2013; 80: 130-131
• 41 Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205-1212
• 42 Gobin YP, Starkman S, Duckwiler GR et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004; 35: 2848-2854
• 43 Broderick JP, Palesch YY, Demchuk AM et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903
• 44 Kidwell CS, Jahan R, Gornbein J et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-923
• 45 Ciccone A, Valvassori L, Nichelatti M et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-913
• 46 Saver JL, Jahan R, Levy EI et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249
• 47 Nogueira RG, Lutsep HL, Gupta R et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380: 1231-1240
• 48 Berkhemer OA, Fransen PS, Beumer D et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20
• 49 van den Berg LA, Koelman DL, Berkhemer OA et al. Type of anesthesia and differences in clinical outcome after intra-arterial treatment for ischemic stroke. Stroke 2015; 46: 1257-1262
• 50 Goyal M, Demchuk AM, Menon BK et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med 2015; 372: 1019-1030
• 51 Campbell BC, Mitchell PJ, Kleinig TJ et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. N Engl J Med 2015; 372: 1009-10018
• 52 Jovin TG, Chamorro A, Cobo E et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296-2306
• 53 Saver JL, Goyal M, Bonafe A et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285-2295